Inventaire - your friends and communities are your best library

Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease

author

Lisa C. Bratzke

Henrik Zetterberg

1973 -

Kaj Blennow

Sterling C. Johnson

Carey E. Gleason

Barbara B Bendlin

Cynthia M Carlsson

Ozioma C Okonkwo

Howard Rowley

Mark A Sager

Siobhan M Hoscheidt

N Maritza Dowling

Nagesh Adluru

published in: Journal of Alzheimer's Disease

date of publication: 2016-01-22

main subject: microglia, cerebrospinal fluid, microstructure, Alzheimer's disease

Cites articles 80

Date

Title

Authors

2015-07-06

Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.

David M. Holtzman, John C. Morris, Anne M Fagan, Tammie L. Benzinger, Mateusz S Jasielec, Andrei G Vlassenko, Courtney L Sutphen, Jack H Ladenson
2015-05-15

Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models

Mathias Jucker, Matthias Staufenbiel, Jörg Odenthal
2015-03-09

Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease.

Daniel A. Alcolea, David Bartrés-Faz, Didac Vidal-Piñeiro, María Carmona-Iragui, Eduard Vilaplana
2014-05-01

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

Henrik Zetterberg, Kaj Blennow, Maria Bjerke, Ulf Andreasson
2014-10-01

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography

Oskar Hansson, Henrik Zetterberg, Kaj Blennow, Lennart Minthon, Ulf Andreasson, Sebastian Palmqvist, Rikard Owenius, Douglas Hägerström, David J. Brooks
2014-04-21

White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's disease

Barbara B Bendlin
2014-02-19

Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation

Annie M Racine, Todd E. Barnhart, Barbara B Bendlin
2014-01-01

Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease

José Luis Molinuevo, Mircea Balasa
2014-06-13

Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease

Daniel A. Alcolea, María Carmona-Iragui, Jordi Clarimón, Alzheimer's Disease Neuroimaging Initiative, Eduard Vilaplana
2013-10-10

Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function

Barbara B Bendlin
2013-10-01

Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults

Alzheimer's Disease Neuroimaging Initiative, Michael W. Weiner, John Q. Trojanowski, Clifford Jack, Niklas Mattsson, Leslie M. Shaw, Rachel L Nosheny, Philip S Insel, Duygu Tosun
2013-07-03

Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology

Thor D Stein, Hwan-Ching Tai, Marta Marquié, Beatriz Gomez Perez-Nievas, ALBERTO SERRANO-POZO, William E. Klunk, Ronald C. Petersen, Bradley Hyman, Val J. Lowe
2013-03-28

Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease

Ian B. Malone, Timothy J. Shakespeare, John S Thornton, Gerard R. Ridgway, Nick C. Fox, Sebastian J Crutch, Martin Rossor, Sebastien Ourselin, Laura Mancini, Natalie Castellanos-Ryan, Shiva Keihaninejad, Marc Modat, Manja Lehmann, Daniel C Alexander
2013-02

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

David S Knopman, Ronald C. Petersen, Prashanthi Vemuri, Heather J Wiste, Stephen Weigand, John Q. Trojanowski, Paul S. Aisen, Nathan Pankratz
2013-03-06

Voxel-based diffusion tensor imaging of an APP/PS1 mouse model of Alzheimer's disease

Yuanyuan Qin
2013-01-01

Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia.

Bob Olsson, Katarina Nägga, Oskar Hansson, Henrik Zetterberg, Kaj Blennow, Lennart Minthon, Kina Höglund, Joakim Hertze, Ronald Lautner, Hans Basun, Lars Lannfelt
2012-11-07

Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome

Alvaro O Ardiles
2012-11-06

Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study

Kewei Chen, Anne M Fagan, Eric M. Reiman, Kenneth S. Kosik, Gene E. Alexander
2012

CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease

Henrik Zetterberg, Kaj Blennow, Sterling C. Johnson, Barbara B Bendlin, Cynthia M Carlsson, Ozioma C Okonkwo, Howard Rowley, Luigi Puglielli, Mark A Sager
2012-01-30

CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease

Oskar Hansson, Sabina Janciauskiene, Lennart Minthon
2012-10-24

Effects of APOE on brain white matter microstructure in healthy adults.

Lars T. Westlye, Ivar Reinvang, Thomas Espeseth
2011-10

Role of family history for Alzheimer biomarker abnormalities in the adult children study

Abraham Z. Snyder, David M. Holtzman, John C. Morris, Anne M Fagan, Tammie L. Benzinger, Mark A. Mintun, Catherine M Roe, Janet M Duchek, Virginia D Buckles, Martha Storandt
2011-04-21

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Clifford Jack, William E. Klunk, Martin Rossor, David S Knopman, John C. Morris, Philip Scheltens, Bradley Hyman, Howard Chertkow, Maria C Carrillo, Guy M McKhann, Sandra Weintraub, Creighton H Phelps, Jennifer J Manly, Richard Mayeux
2011-05

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Laurel A. Beckett, Clifford Jack, Jeffrey Kaye, Yaakov Stern, David A Bennett, Maria C Carrillo, Anne M Fagan, Eric M. Reiman, Kristine Yaffe, Paul S. Aisen, Reisa Sperling, Eric R Siemers, Suzanne Craft, Marcelle Morrison-Bogorad, Creighton H Phelps, Thomas J Montine
2011-02-23

A Bayesian model of shape and appearance for subcortical brain segmentation

Mark Jenkinson, Stephen M. Smith
2011-07-05

CCL2/MCP-1 modulation of microglial activation and proliferation

Borja García-Bueno, Juan Carlos Leza, José L.M. Madrigal
2011-11-18

An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis

Christian Gaser, Annette Förschler, Volker J Schmid, Dorothea Buck, Claus Zimmer
2010-11-01

YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease

Mark A. Mintun, David M. Holtzman, John C. Morris, Anne M Fagan, Nigel J Cairns, Catherine M Roe, Richard J Perrin, D Galasko, Gina D'Angelo, Deborah McCarter-Spaulding, Elaine Peskind, Rebecca Craig-Schapiro, R Reid Townsend, Joseph Quinn
2010-11-03

Neuronal MCP-1 mediates microglia recruitment and neurodegeneration induced by the mild impairment of oxidative metabolism

Zun-Ji Ke
2010-08-14

White matter is altered with parental family history of Alzheimer's disease

Mariana Lazar, Elisa Canu, Barbara B Bendlin
2010-03-01

Mechanisms underlying inflammation in neurodegeneration

Beate Winner, Fred Gage, Maria C Marchetto
2010-01-01

Microstructural diffusion changes are independent of macrostructural volume loss in moderate to severe Alzheimer's disease

Francesca B. Pizzini, Giuseppe K Ricciardi, Elisa Canu, Barbara B Bendlin, Giovanni B. Frisoni

Article - wd:Q36599172

Welcome to Inventaire

the library of your friends and communities

learn more